JP2023544404A5 - - Google Patents

Info

Publication number
JP2023544404A5
JP2023544404A5 JP2023520423A JP2023520423A JP2023544404A5 JP 2023544404 A5 JP2023544404 A5 JP 2023544404A5 JP 2023520423 A JP2023520423 A JP 2023520423A JP 2023520423 A JP2023520423 A JP 2023520423A JP 2023544404 A5 JP2023544404 A5 JP 2023544404A5
Authority
JP
Japan
Prior art keywords
compound according
independently
alkyl
cr7r8
appearance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023520423A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023544404A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/053320 external-priority patent/WO2022076285A1/en
Publication of JP2023544404A publication Critical patent/JP2023544404A/ja
Publication of JP2023544404A5 publication Critical patent/JP2023544404A5/ja
Pending legal-status Critical Current

Links

JP2023520423A 2020-10-06 2021-10-04 Kv1.3カリウムSHAKERチャネル遮断剤としてのラクタム化合物 Pending JP2023544404A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063088171P 2020-10-06 2020-10-06
US63/088,171 2020-10-06
PCT/US2021/053320 WO2022076285A1 (en) 2020-10-06 2021-10-04 LACTAM COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS

Publications (2)

Publication Number Publication Date
JP2023544404A JP2023544404A (ja) 2023-10-23
JP2023544404A5 true JP2023544404A5 (enExample) 2024-10-16

Family

ID=81126843

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023520423A Pending JP2023544404A (ja) 2020-10-06 2021-10-04 Kv1.3カリウムSHAKERチャネル遮断剤としてのラクタム化合物

Country Status (11)

Country Link
US (1) US20230373952A1 (enExample)
EP (1) EP4225285A4 (enExample)
JP (1) JP2023544404A (enExample)
KR (1) KR20230082041A (enExample)
CN (1) CN116782894A (enExample)
AU (1) AU2021358700A1 (enExample)
BR (1) BR112023005387A2 (enExample)
CA (1) CA3193554A1 (enExample)
IL (1) IL301627A (enExample)
MX (1) MX2023003841A (enExample)
WO (1) WO2022076285A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4610260A4 (en) * 2022-10-28 2025-11-26 Shanghai Shenshi Wise Tech Co Ltd Aryl heterocyclic kv1.3 inhibitor, preparation method therefor, and use thereof
EP4700015A1 (en) 2023-04-19 2026-02-25 Shanghai Henlius Biotech, Inc. Heterocyclic ring-substituted aromatic compound, preparation method therefor, and use thereof
CN121712744A (zh) * 2023-07-26 2026-03-20 上海汇伦医药股份有限公司 芳基含氮杂环化合物、药物组合物和应用
TW202521512A (zh) 2023-07-31 2025-06-01 美商美國禮來大藥廠 Kv1.3鉀shaker通道阻斷劑之固體形式及其使用方法
WO2025235367A1 (en) * 2024-05-06 2025-11-13 D. E. Shaw Research, Llc Azaindolinone compounds as kca3.1 potassium channel blockers
WO2025235362A1 (en) * 2024-05-06 2025-11-13 D. E. Shaw Research, Llc INDOLINONE COMPOUNDS AS KCa3.1 POTASSIUM CHANNEL BLOCKERS

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4675189A (en) 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5407686A (en) 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US6174908B1 (en) 1999-05-10 2001-01-16 Icagen, Inc. Potassium channel inhibitors
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
WO2004037784A2 (en) * 2002-10-21 2004-05-06 Irm Llc Pyrrolidones with anti-hiv activity
JP5186213B2 (ja) * 2004-09-29 2013-04-17 田辺三菱製薬株式会社 タウプロテインキナーゼ1阻害剤としての6−ピリジニル−4−ピリミドン誘導体
BRPI0607294A2 (pt) * 2005-01-28 2009-08-25 Irm Llc processos para sìntese de aril pirrolidonas, bem como mistura
WO2011073273A1 (en) 2009-12-16 2011-06-23 Evotec Ag Benzoxazine aryl sulfonamide derivatives as kv1.3 modulators
CN101979378B (zh) * 2010-10-13 2012-06-27 中国科学院上海有机化学研究所 一种手性γ-内酰胺化合物的合成方法
TW201249844A (en) * 2010-12-20 2012-12-16 Incyte Corp N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
CA2952732C (en) * 2014-06-25 2024-01-02 Sanford-Burnham Medical Research Institute Small molecule agonists of neurotensin receptor 1
AU2020363354A1 (en) 2019-10-07 2022-04-21 D.E. Shaw Research, Llc Aryl heterobicyclic compounds as Kv1.3 potassium shaker channel blockers
BR112022006292A2 (pt) 2019-10-07 2022-06-28 De Shaw Res Llc Compostos heterobicílicos de arila como bloqueadores de canais de agitador de potássio kv1.3
EP4041229A4 (en) 2019-10-07 2023-10-25 D.E. Shaw Research, LLC Arylmethylene heterocyclic compounds as kv1.3 potassium shaker channel blockers
MX2022004145A (es) 2019-10-07 2022-06-14 De Shaw Res Llc Compuestos heterociclicos de arilmetileno como bloqueadores del canal de potasio tipo shaker kv1.3.
BR112022006242A2 (pt) 2019-10-07 2022-06-21 De Shaw Res Llc Compostos aromáticos de arilmetileno como bloqueadores de canal do agitador de potássio kv1,3
CN114746151A (zh) 2019-10-07 2022-07-12 D·E·萧尔研究有限责任公司 作为Kv1.3钾Shaker通道阻断剂的芳基杂环化合物

Similar Documents

Publication Publication Date Title
JP2022552445A5 (enExample)
JP2019163290A5 (enExample)
JP2025504486A5 (enExample)
JP2021523200A5 (enExample)
JP2022553841A5 (enExample)
RU2018127360A (ru) Производные бензимидазола в качестве модуляторов ror-гамма
JP2022529311A5 (enExample)
JP2010519204A5 (enExample)
ES2752552T3 (es) Métodos de proceso para inhibidores de fosfatidilinositol 3-quinasa
JP2017505808A5 (enExample)
JP2016521710A5 (enExample)
JP2022519239A5 (enExample)
JP2010509342A5 (enExample)
JP2021533087A5 (enExample)
JP2018531218A5 (enExample)
IL308277A (en) Spiroindolinone compounds as kv1.3 potassium shaker channel blockers
EA037643B1 (ru) Замещенные фенилоксазолидиноны для антимикробной терапии
JP2024512931A5 (enExample)
JP2020521739A5 (enExample)
JP2020506906A (ja) Jak酵素阻害剤及びその製造方法と用途
JP2022526553A5 (enExample)
JP2019500374A5 (enExample)
JP2024533990A5 (enExample)
JP2020520925A5 (enExample)
JP2022518523A5 (enExample)